NXTS Nexentis Technologies Inc.
1.380USD-7.38%Mkt Cap: 2.01M $P/E: —1d ago
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The…
Industry Peers
Agricultural InputsKey Statistics
Company
Market Cap2.01M USD
Enterprise Value-6.41M USD
Revenue (TTM)—
Gross Profit2.00K USD
Net Income (TTM)-4.00M USD
Revenue/Share—
Last Price1.380 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7
CountryUS
SectorBasic Materials
IndustryAgricultural Inputs
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA1.07
EV/Revenue—
P/S—
P/B1.14
EPS (TTM)-21.55
EPS (Forward)—
52W Range
1.1400% of range50.96
52W High50.96 USD
52W Low1.140 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-25.01%
ROA-19.62%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.81M USD
CapEx (TTM)14.00K USD
FCF Margin—
FCF Yield-273.27%
Net Debt-8.45M USD
Net Debt/EBITDA1.42
Balance Sheet
Debt/Equity0.06
Current Ratio3.72
Quick Ratio3.18
Book Value/Sh1.31 USD
Cash/Share6.11 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:7
Split DateApr 8, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.45M
Float1.14M
Insiders21.17%
Institutions4.36%
Short Interest
Short Ratio1.6d
Short % Float2.95%
Short % Out.2.72%
Shares Short39.46K
Short (prev mo.)62.68K
Technical
SMA 501.688 (-18.2%)
SMA 2005.423 (-74.6%)
Beta1.87
S&P 52W Chg14.58%
Avg Vol (30d)31.47K
Avg Vol (10d)63.54K
Technical Indicators
RSI (14)36.7
MACD-0.1717
MACD Signal-0.2121
MACD Hist.+0.0404
BB Upper1.761 USD
BB Middle1.505 USD
BB Lower1.249 USD
BB Width33.96%
ATR (14)0.1838 USD
Vol Ratio (20d)0.09x